论文部分内容阅读
目的:探讨纳洛酮联合痰热清注射液辅助治疗肺性脑病的疗效,以提高临床治疗水平。方法:将2009年6月-2012年12月我院收治的呼吸衰竭并肺性脑病患者80例随机分为观察组和对照组各40例,观察组给予纳洛酮联合痰热清治疗,对照组给予常规西医治疗,比较两组的治疗效果。结果:观察组的总有效率92.5%明显高于对照组的62.5%(P<0.05)。结论:采用纳洛酮联合痰热清注射液辅助治疗肺性脑病的疗效显著,建议临床应用推广。
Objective: To investigate the efficacy of naloxone combined with Tanreqing Injection in the treatment of pulmonary encephalopathy in order to improve the clinical treatment level. Methods: Eighty patients with respiratory failure and pulmonary encephalopathy admitted to our hospital from June 2009 to December 2012 were randomly divided into observation group (40 cases) and control group (n = 40). The observation group was treated with naloxone and Tanreqing. Group given conventional Western medicine, the treatment effect of the two groups were compared. Results: The total effective rate in observation group was significantly higher than that in control group (92.5% vs 62.5%, P <0.05). Conclusion: Naloxone combined with Tanreqing injection in the treatment of pulmonary encephalopathy has a significant effect, it is recommended to promote clinical application.